06:09 AM EDT, 07/03/2024 (MT Newswires) -- Identiv ( INVE ) said late Tuesday its stockholders approved the asset sale transaction with security solutions provider Vitaprotech for $145 million in cash.

About 96% of the shares voted were in favor of the asset sale proposal as recommended by the company's board, representing about 72% of the company's outstanding shares.

The company said that the only outstanding regulatory condition to closing is clearance from the Committee on Foreign Investment in the US. The transaction remains on track to close in Q3.